Bocouture 100IU vial

Key Features: Botulinum neurotoxin type A blocks cholinergic transmission at the neuromuscular junction by inhibiting the release of acetylcholine Bocouture is free from complexing proteins Treatment Areas: Glabellar frown lines Periorbital lines Horizontal forehead lines Composition: Botulinum toxin type A, free from complexing proteins. The additional ingredients are human albumin and sucrose. Contraindications of Bocouture: Hypersensitivity to the active substance or any of the excipients Generalised disorders of muscle activity (e.g. myasthenia gravis, Lambert- Eaton syndrome) Infection or inflammation at the proposed injection site Who Should Not Use Bocouture? The injection of Bocouture is not recommended for patients with a history of aspiration or dysphagia Patients suffering from amyotrophic lateral sclerosis Patients with other diseases which result in peripheral neuromuscular dysfunction In targeted muscles that display pronounced weakness or atrophy Additional Information: EMC: https://www.medicines.org.uk/emc/product/600/smpc Patient Information Leaflet: https://www.medicines.org.uk/emc/files/pil.600.pdf